Clinical Trial - Trial ChiCTR2200056655
Access comprehensive clinical trial information for ChiCTR2200056655 through Pure Global AI's free database. This Phase 2 trial is sponsored by The First Affiliated Hospital of Henan University of CM and is currently Not yet recruiting. The study focuses on Lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200056655
Phase 2
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200056655
View on Chinese Clinical Trial Registry
Untitled Trial
Anlotinib combined with penpulimab in patients with advanced solid tumors: a single-arm, prospective clinical study
Study Focus
Sponsor & Location
The First Affiliated Hospital of Henan University of CM
Self-funded
China
Timeline & Enrollment
Phase 2
N/A
Jun 15, 2024
ICD-10 Classifications
Carcinoma in situ: Bronchus and lung
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm: Overlapping lesion of bronchus and lung
Data Source
Chinese Clinical Trial Registry
ChiCTR2200056655
Non-Device Trial